PA8785701A1 - COMBINED PHARMACEUTICAL COMPOSITION - Google Patents

COMBINED PHARMACEUTICAL COMPOSITION

Info

Publication number
PA8785701A1
PA8785701A1 PA20088785701A PA8785701A PA8785701A1 PA 8785701 A1 PA8785701 A1 PA 8785701A1 PA 20088785701 A PA20088785701 A PA 20088785701A PA 8785701 A PA8785701 A PA 8785701A PA 8785701 A1 PA8785701 A1 PA 8785701A1
Authority
PA
Panama
Prior art keywords
carriers
pharmaceutical composition
combination
combined pharmaceutical
composition
Prior art date
Application number
PA20088785701A
Other languages
Spanish (es)
Inventor
Arzola Paniagua Angelica
Eduardo Santillana Portocarrero Jose
Keyla Corona Ramirez Martha
Original Assignee
Lab Senosiain S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40228222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8785701(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lab Senosiain S A De C V filed Critical Lab Senosiain S A De C V
Publication of PA8785701A1 publication Critical patent/PA8785701A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA EN CÁPSULAS CON MICROESFERAS RECUBIERTAS QUE COMPRENDE LA COMBINACIÓN DE BESILATO DE AMLODIPINO Y PRAVASTATINA SÓDICA Y SUS SALES FARMACÉUTICAMENTE ACEPTABLES, ADICIONALMENTE VEHÍCULOS O EXCIPIENTES FARMACÉUTICAMENTE ACEPTABLES, ADICIONALMENTE VEHÍCULOS O EXCIPIENTES FARMACÉUTICAMENTE ACEPTABLES ; ASÍ COMO A UN PROCESO PARA LA FABRICACIÓN DE LA COMPOSICIÓN Y AL USO DE DICHA COMBINACIÓN PARA LA PREPARACIÓN DE UN MEDICAMENTO CON ACTIVIDAD TERAPÉUTICA SINÉRGICA INDICADO EN EL TRATAMIENTO DE PADECIMIENTOS CARDIOVASCULARES DEL TIPO DE HIPERTENSIÓN ARTERIAL Y DISLIPIDÉMIA Y SU COMORBILIDAD.The present invention relates to a pharmaceutical CAPSULES COATED COMPOSITION microsphere comprising the combination of amlodipine besylate and pravastatin sodium, and their pharmaceutically acceptable salts, IN ADDITION VEHICLES or carriers, in addition VEHICLES or carriers; AS WELL AS A PROCESS FOR THE MANUFACTURE OF THE COMPOSITION AND THE USE OF SUCH COMBINATION FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SYNERGIC THERAPEUTIC ACTIVITY INDICATED IN THE TREATMENT OF CARDIOVASCULAR HANDLING AND DISLIPIDABILITY HYPERTENSION TYPE.

PA20088785701A 2007-07-11 2008-06-25 COMBINED PHARMACEUTICAL COMPOSITION PA8785701A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007008440A MX2007008440A (en) 2007-07-11 2007-07-11 Combined pharmaceutical composition.

Publications (1)

Publication Number Publication Date
PA8785701A1 true PA8785701A1 (en) 2009-04-23

Family

ID=40228222

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088785701A PA8785701A1 (en) 2007-07-11 2008-06-25 COMBINED PHARMACEUTICAL COMPOSITION

Country Status (7)

Country Link
AR (1) AR067110A1 (en)
CL (1) CL2008001895A1 (en)
MX (1) MX2007008440A (en)
PA (1) PA8785701A1 (en)
PE (1) PE20090439A1 (en)
UY (1) UY31153A1 (en)
WO (1) WO2009007808A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101804055B (en) * 2010-04-27 2012-01-25 施慧达药业集团(吉林)有限公司 Compound medicinal preparation
MX351059B (en) * 2012-08-17 2017-09-29 Laboratorios Senosiain S A De C V Star Oral pharmaceutical composition in the form of microspheres and preparation method.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000124A (en) * 1997-08-29 1999-02-09 Pfizer Prod Inc COMBINATION THERAPY
AU2001284413A1 (en) * 2000-08-30 2002-03-13 Sankyo Company Limited Medicinal compositions for preventing or treating heart failure

Also Published As

Publication number Publication date
MX2007008440A (en) 2009-02-18
WO2009007808A4 (en) 2009-03-05
WO2009007808A1 (en) 2009-01-15
CL2008001895A1 (en) 2008-08-22
UY31153A1 (en) 2009-03-02
PE20090439A1 (en) 2009-05-24
AR067110A1 (en) 2009-09-30

Similar Documents

Publication Publication Date Title
ES2916649T1 (en) Compositions and uses for the treatment of multiple sclerosis
AR060019A1 (en) PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER
UY31918A (en) FGFR INHIBITING PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES FOR THE PREPARATION AND USE AS A MEDICINAL PRODUCT
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
SV2010003451A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
UY30438A1 (en) N-SUBSTITUTED DERIVATIVES OF 5-HALO-4- [2-RENT-1-SUBSTITUTES-1H-IMIDAZOL-5-IL] PIRIMIDIN-2-AMINA, COMPOSITIONS-PROCESSES FOR PREPARATION AND USES
CO6341565A2 (en) HEPATITIS C SERINA PROTEASAS MACROCICLIC INHIBITORS
DOP2006000057A (en) PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
CO6491060A2 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
UY31741A (en) CAPSULE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES
BR112013002814A2 (en) use of salvia miltiorrhiza-based composition in drug preparation for secondary prevention of heart disease
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
CR20110704A (en) COMPOSITIONS OF FIXED DOSAGE SOLID PHARMACEUTICALS THAT INCLUDE IRBESARTAN AND AMYLODIPINE, ITS PREPARATION AND THERAPEUTIC APPLICATION
UY31922A (en) COMPOUNDS
CL2007000781A1 (en) NANOPARTICLES THAT INCLUDE A THYROSINE KINASE INHIBITOR RECEIVING THE GROWTH FACTOR DERIVED FROM PLATES; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF VASCULAR DISEASES, SUCH AS RESTENOSIS
WO2010127205A3 (en) Fixed dose drug combination formulations
ATE526015T1 (en) MEDICINAL PRODUCTS AND THEIR PRODUCTION AND USE IN THE TREATMENT OF PAINFUL NEUROPATHIES
CR11869A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
CL2013003176A1 (en) Sustained-release oral pharmaceutical formulation comprising two tablets containing 1000 mg of paracetamol, which is present in a sustained-release layer and another of immediate release, in a proportion of paracetamol per layer of 80-90%: 10-20% , where the unit dose comprises 2000 mg paracetamol.
UY31790A (en) USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATININE LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONA
PA8785701A1 (en) COMBINED PHARMACEUTICAL COMPOSITION
DOP2011000267A (en) ORAL PHARMACEUTICAL COMPOSITION FOR USE IN RESPIRATORY DISEASES
BRPI0813658A2 (en) compound, medicament, pharmaceutical composition, combined pharmaceutical preparation, uses of a compound and a combined preparation, and process for the preparation of compound.
AR078107A1 (en) USE OF IRBESARTAN FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION OF HOSPITALIZATION BY CARDIAC INSUFFICIENCY
AR078798A1 (en) USE OF CELIVARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATININE LEVEL DUE TO THE ADMINISTRATION OF CELIVARONA